Cellular thermal shift assay (CETSA) was employed to monitor the cellular target engagement of CC1007 and verify whether CC1007 could directly interact with MEF2C in BCR-ABL1− pre-B-ALL cells. This evidence concerns the gene MEF2C and acute lymphoblastic leukemia.